Lewis Vidler PhD

Dr Lewis Vidler is a Senior Director of Structure-Based Drug Design at Eli Lilly. He achieved a first-class chemistry degree at the University of Oxford in 2009 and subsequently completed his PhD in Computational Medicinal Chemistry at the Institute of Cancer Research in London in 2013. He joined Lilly later that year and spent an initial duration of 7 years there, during which he progressed to Senior Research Scientist. Following shorter stints as a computational chemist at UCB and Amphista Therapeutics, he returned to Eli Lilly earlier this year to further progress his career.